UnitedHealth (UNH) reported disappointing second-quarter results due to rising medical costs and projected full-year earnings up to 22.5% below analysts’ estimates. As the worst performer in the Dow Jones this year, UNH’s stock continued to decline amid concerns over increasing costs per patient encounter.
Read more@
